Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of the 2nd IUIS/WHO collaborative study
| Autor: | R. Jefferis, C.B. Reimer, F. Skvaril, G.G. de Lange, D.M. Goodall, T.L. Bentley, D.J. Phillips, A. Vlug, S. Harada, J. Radl, E. Claassen, J.A. Boersma, J. Coolen |
|---|---|
| Rok vydání: | 1992 |
| Předmět: |
Immunology
Antibodies Monoclonal Reference Standards World Health Organization Antibodies Anti-Idiotypic Immunoglobulin Isotypes Epitopes Antibody Specificity Evaluation Studies as Topic Immunoglobulin G Immunologic Techniques Humans Immunology and Allergy Indicators and Reagents Immunoglobulin Allotypes |
| Zdroj: | Immunology Letters. 31:143-168 |
| ISSN: | 0165-2478 |
| DOI: | 10.1016/0165-2478(92)90141-a |
| Popis: | Following the 1st IUIS/WHO Collaborative Study of monoclonal anti-IgG subclass antibodies, a panel of WHO Specificity Reference Reagents (SRR) was established [Jefferis, R., et al. (1985) Immunol. Lett., 10, 223]. At the time, the hope was expressed that further reagents particularly for IgG2, and other allotypic specificities would become available which could be applied in a wide range of assay protocols. The 2nd study reports the evaluation of nineteen anti-subclass and seven anti-allotype monoclonal antibodies. The anti-IgG1 antibody HP6187 was equivalent in performance to the SRR. Others, that were not of the mouse IgG1 isotype, may be useful for particular applications. The anti-IgG2 antibody HP6200 could be a valuable addition to the WHO SRR; it is specific for an epitope in the Fab region but does not have the light chain bias of HP6014. Antibodies of putative allotype specificity exhibited the claimed specificity when used within protocols similar to those employed by the originating laboratory. It appears to be inherent in the nature of the epitopes (allotopes) recognized that it will take several years before reagents applicable to a wide range of techniques will become available. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|